Ken Griffin Teva Pharmaceutical Industries LTD Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Citadel Advisors LLC holds 2,309,200 shares of TEVA stock, worth $39.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,309,200
Previous 3,956,700
41.64%
Holding current value
$39.3 Million
Previous $64.3 Million
35.28%
% of portfolio
0.01%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding TEVA
# of Institutions
624Shares Held
573MCall Options Held
19.6MPut Options Held
6.77M-
Black Rock Inc. New York, NY43MShares$732 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.2MShares$617 Million35.87% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L334.5MShares$588 Million5.5% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$491 Million3.32% of portfolio
-
Exor Capital LLP London, X026.5MShares$451 Million14.79% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.9B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...